Abstract
Existing data on the incidence of multiple sclerosis (MS) in the UK have some limitations. Few studies have reported age- and sex-specific incidence rates of MS, and none of those is based on a large sample of the general population. Further, no published reports have provided age- and sex-specific incidence rates of MS by clinical course from onset. To estimate the age- and sex-specific incidence rate and lifetime risk of multiple sclerosis, we identified all new cases of MS during the period 1993–2000 in the General Practice Research Database, which includes health information on over three million Britons. Based on 642 incident cases, incidence rates of MS adjusted to the world population were 7.2 (95 % CI 6.5, 7.8) in women and 3.1 (95 % CI 2.6, 3.5) in men. The incidence of MS with relapsing-remitting onset was higher in women than in men (incidence rate ratio 2.5, 95% CI 2.1, 3.1), but there were no sex differences for primary-progressive MS (incidence rate ratio 1.1, 95% CI 0.7, 1.8). The estimated lifetime risk from birth of receiving an MS diagnosis was 5.3 per 1,000 in women and 2.3 per 1,000 in men. These results confirm the relatively high incidence of MS in the UK and show marked differences in the sex-specific pattern of MS incidence by clinical course from onset.
Similar content being viewed by others
References
Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952
Zivadinov R, Iona L, Monti-Bragadin L, et al. (2003) The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. Neuroepidemiology 22:65–74
Pugliatti M, Rosati G, Carton H, et al. (2006) The epidemiology of multiple sclerosis in Europe. Eur J Neurol 13:700–722
Villard-Mackintosh L,Vessey MP (1993) Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47:161–168
Thorogood M, Hannaford PC (1998) The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 105:1296–1299
Murray S, Bashir K, Penrice G, Womersley J (2004) Epidemiology of multiple sclerosis in Glasgow. Scott Med J 49:100–104
Jick H, Jick SS, Derby LE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302:766–768
Jick SS, Kaye JA,Vasilakis-Scaramozza C, et al. (2003) Validity of the General Practice Research Database. Pharmacotherapy 23:686–689
Hollowell J (1997) The General Practice Research Database: quality of morbidity data. Popul Trends 87:36–40
Poser CM, Paty DW, Scheinberg L, et al. (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227–231
McDonald WI, Compston A, Edan G, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M (2002) Age standardization of rates: a new WHO standard. GPE Discussion Paper Series No. 31.World Health Organization, Geneva
Rothman KJ,Greenland S (1998) Measures of disease frequency. In: Rothman KJ,Greenland S (eds) Modern Epidemiology. Lippincott Williams and Wilkins, Philadelphia, pp 29–46
Statistical Research and Applications Branch – National Cancer Institute. DevCan: Probability of Developing or Dying of Cancer Software (computer program). Version 5.3; 2004
Fay MP, Pfeiffer R, Cronin KA, Le C, Feuer EJ (2003) Age-conditional probabilities of developing cancer. Stat Med 22:1837–1848
Fay MP (2004) Estimating age conditional probability of developing disease from surveillance data. Popul Health Metr 2:6
Office for National Statistics (2003) Series DH1 No. 34.Mortality statistics general. Review of the Registrar General on deaths in England and Wales, 2001. Office for National Statistics, London,UK
McDonnell GV,Hawkins SA (2002) Primary progressive multiple sclerosis: increasing clarity but many unanswered questions. J Neurol Sci 199:1–15
Midgard R, Riise T, Svanes C,Kvale G, Nyland H (1996) Incidence of multiple sclerosis in More and Romsdal,Norway from 1950 to 1991. An age-periodcohort analysis. Brain 119:203–211
Koch-Henriksen N (1999) The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 5:293–296
Sundstrom P,Nystrom L, Forsgren L (2003) Incidence (1988–97) and prevalence (1997) of multiple sclerosis in Vasterbotten County in northern Sweden. J Neurol Neurosurg Psychiatr 74:29–32
Sarasoja T,Wikstrom J, Palmataa J, Hakama M, Sumelahti ML (2004) Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years. Acta Neurol Scand 110:331–336
Hennessy A, Swingler RJ, Compston DA (1989) The incidence and mortality of multiple sclerosis in south east Wales. J Neurol Neurosurg Psychiatr 52:1085–1089
Mumford CJ, Fraser MB,Wood NW, Compston DA (1992) Multiple sclerosis in the Cambridge health district of east Anglia. J Neurol Neurosurg Psychiatr 55:877–882
Robertson N, Deans J, Fraser M, Compston DA (1996) Multiple sclerosis in south Cambridgeshire: incidence and prevalence based on a district register. J Epidemiol Community Health 50:274–279
Rothwell PM, Charlton D (1998) High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition. J Neurol Neurosurg Psychiatr 64:730–735
MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD (2000) The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 123:665–676
Ford HL,Gerry E, Johnson M,Williams R (2002) A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol 249:260–265
Tremlett H, Paty D, Devonshire V (2005) The natural history of primary progressive multiple sclerosis in British Columbia, Canada. Neurology 65:1919–1923
Granieri E, Malagu S, Casetta I, et al. (1996) Multiple sclerosis in Italy.A reappraisal of incidence and prevalence in Ferrara. Arch Neurol 53:793–798
Barnett MH, Williams DB, Day S, Macaskill P, McLeod JG (2003) Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study. J Neurol Sci 213:1–6
Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R (2004) Multiple sclerosis in Nord-Trondelag County,Norway: a prevalence and incidence study. Acta Neurol Scand 109:378–384
Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM (2006) A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway. Neurology 66:182–186
Pugliatti M, Riise T, Sotgiu MA, et al. (2005) Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology 25:129–134
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alonso, A., Jick, S.S., Olek, M.J. et al. Incidence of multiple sclerosis in the United Kingdom. J Neurol 254, 1736–1741 (2007). https://doi.org/10.1007/s00415-007-0602-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-007-0602-z